The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A12 | Mineral supplements | |
| 3 | A12B | Potassium | |
| 4 | A12BA | Potassium | |
| 5 | A12BA01 | Potassium chloride |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 3 g |
| Active Ingredient | Description | |
|---|---|---|
| Potassium chloride |
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| K-TAB Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| KLOR-CON Extended-release tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| KLOR-CON Powder for oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| POTASSIUM CHLORIDE Concentrate for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| SLOW K Coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
